ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Down 15.5 %

OBSV opened at $0.10 on Friday. The stock’s 50 day simple moving average is $0.01. The company has a market cap of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. ObsEva has a fifty-two week low of $0.08 and a fifty-two week high of $2.14.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.